{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:27:34Z","timestamp":1791329254616,"version":"4.3.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/pas.0b013e31826cabbd","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T12:41:00Z","timestamp":1355229660000},"page":"138-146","source":"Crossref","is-referenced-by-count":55,"title":["BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian High-Grade Serous Carcinomas"],"prefix":"10.1097","volume":"37","author":[{"given":"Karuna","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narciso","family":"Olvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bisogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles Alvarez","family":"Secord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Cerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210131","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary.","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-17-20210131","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1200\/JCO.2009.27.5719","article-title":"Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.","volume":"28","author":"Konstantinopoulos","year":"2010","journal-title":"J Clin Oncol"},{"key":"R4-17-20210131","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma.","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer"},{"key":"R5-17-20210131","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1200\/JCO.2009.27.2997","article-title":"Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.","volume":"28","author":"Hennessy","year":"2010","journal-title":"J Clin Oncol"},{"key":"R6-17-20210131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R7-17-20210131","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R8-17-20210131","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.pas.0000213428.61374.06","article-title":"Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.","volume":"31","author":"Modica","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R9-17-20210131","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1200\/JCO.2010.32.9979","article-title":"Testing women with endometrial cancer to detect Lynch syndrome.","volume":"29","author":"Kwon","year":"2011","journal-title":"J Clin Oncol"},{"key":"R10-17-20210131","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/AOG.0b013e3181b11ecc","article-title":"Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.","volume":"114","author":"Resnick","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R11-17-20210131","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1245\/s10434-007-9372-1","article-title":"Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.","volume":"14","author":"King","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R12-17-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1349-7006.2000.tb00959.x","article-title":"Screening of BRCA1 mutation using immunohistochemical staining with C-terminal and N-terminal antibodies in familial ovarian cancers.","volume":"91","author":"Kashima","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"R13-17-20210131","first-page":"949","article-title":"An antibody assay predictive of BRCA1 mutations in ovarian tumors and normal tissue.","volume":"7","author":"Byrne","year":"2000","journal-title":"Oncol Rep"},{"key":"R14-17-20210131","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ygyno.2011.08.017","article-title":"BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.","volume":"123","author":"Carser","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R15-17-20210131","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/IGC.0b013e318227c990","article-title":"Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer.","volume":"21","author":"Radosa","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R16-17-20210131","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/annonc\/mdq770","article-title":"Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study.","volume":"22","author":"Weberpals","year":"2011","journal-title":"Ann Oncol"},{"key":"R17-17-20210131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1600-0412.2011.01121.x","article-title":"Identification of BRCA1-deficient ovarian cancers.","volume":"90","author":"Skytte","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R18-17-20210131","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1369\/jhc.7A7209.2007","article-title":"Familial breastovarian cancer and BRCA12 genetic screening: the role of immunohistochemistry as an additional method in the selection of patients.","volume":"55","author":"Vaz","year":"2007","journal-title":"J Histochem Cytochem"},{"key":"R19-17-20210131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"R20-17-20210131","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnci\/djq509","article-title":"Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.","volume":"103","author":"Drew","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R21-17-20210131","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/cc.10.8.15273","article-title":"Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.","volume":"10","author":"Dedes","year":"2011","journal-title":"Cell Cycle"},{"key":"R22-17-20210131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-61779-270-0_17","article-title":"Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy.","volume":"780","author":"Ibragimova","year":"2011","journal-title":"Methods Mol Biol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0b013e31826cabbd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:57:37Z","timestamp":1620968257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201301000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31826cabbd","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}